Background Many patients with type 2 diabetes mellitus (T2DM) sub-optimally adhere to core treatment recommendations, such as healthy diets, sufficient physical activity and pharmacological support. This paper describes the development of the web-based computer-tailored program My Diabetes Profile (MDP), incorporating identified success factors of web-based interventions, and the protocol for testing the effectiveness of this program in a randomized multicentre trial.Methods: Formative research - including the input of a program committee, qualitative and quantitative studies with patients and health professionals and a literature search - yielded input for the development of the MDP program. MDP provides video and text tailored advice, bas...
Background: Type 2 diabetes affects an estimated 347 million people worldwide and often leads to ser...
Background: In the UK, 6% of the UK population have diabetes mellitus, 90% of whom have type 2 diabe...
BACKGROUND: Many patients with type 2 diabetes (T2DM) are not able to reach the glycaemic target lev...
Background Many patients with type 2 diabetes mellitus (T2DM) sub-optimally adhere to core treatment...
Background Many patients with type 2 diabetes mellitus (T2DM) sub-optimally adhere to core treatment...
Adherence of patients with type 2 diabetes to core treatment elements, i.e. healthy lifestyles and m...
Background: Adherence to core type 2 diabetes mellitus (T2DM) treatment behaviors is suboptimal, and...
BACKGROUND: The potential of web-based interventions in dietary behaviour modification of the diabet...
Background: Self-management is recognized as the cornerstone of overall diabetes management. Web-bas...
BACKGROUND: Diabetes is becoming a very important health issue in rapidly developing nations and the...
Background: Type 2 Diabetes Mellitus (T2DM) is common, affecting nearly 400 million people worldwide...
Background: Due to ongoing rise in need for care for people with chronic diseases and lagging increa...
Background: Diabetes is becoming a very important health issue in rapidly developing nations and the...
Background: Medication non-adherence is a prevalent health problem in people with type 2 diabetes me...
Adherence of patients with type 2 diabetes to core treatment elements, i.e. healthy lifestyles and m...
Background: Type 2 diabetes affects an estimated 347 million people worldwide and often leads to ser...
Background: In the UK, 6% of the UK population have diabetes mellitus, 90% of whom have type 2 diabe...
BACKGROUND: Many patients with type 2 diabetes (T2DM) are not able to reach the glycaemic target lev...
Background Many patients with type 2 diabetes mellitus (T2DM) sub-optimally adhere to core treatment...
Background Many patients with type 2 diabetes mellitus (T2DM) sub-optimally adhere to core treatment...
Adherence of patients with type 2 diabetes to core treatment elements, i.e. healthy lifestyles and m...
Background: Adherence to core type 2 diabetes mellitus (T2DM) treatment behaviors is suboptimal, and...
BACKGROUND: The potential of web-based interventions in dietary behaviour modification of the diabet...
Background: Self-management is recognized as the cornerstone of overall diabetes management. Web-bas...
BACKGROUND: Diabetes is becoming a very important health issue in rapidly developing nations and the...
Background: Type 2 Diabetes Mellitus (T2DM) is common, affecting nearly 400 million people worldwide...
Background: Due to ongoing rise in need for care for people with chronic diseases and lagging increa...
Background: Diabetes is becoming a very important health issue in rapidly developing nations and the...
Background: Medication non-adherence is a prevalent health problem in people with type 2 diabetes me...
Adherence of patients with type 2 diabetes to core treatment elements, i.e. healthy lifestyles and m...
Background: Type 2 diabetes affects an estimated 347 million people worldwide and often leads to ser...
Background: In the UK, 6% of the UK population have diabetes mellitus, 90% of whom have type 2 diabe...
BACKGROUND: Many patients with type 2 diabetes (T2DM) are not able to reach the glycaemic target lev...